H.Kent Holland, M.D.
H. Kent Holland, M.D., is board certified in the subspecialties of oncology and hematology. He is Medical Director of the Blood and Marrow Transplant Program at Northside Hospital, Co-Director of the Northside Hospital Stem Cell Processing Laboratory, and Medical Director of the Atlanta Blood Services Apheresis Collection Facility. Dr. Holland is also a Northside Hospital Leukemia and Immunotherapy Program physician. Dr. Holland has been Atlanta's Top Doctor in his specialty from 2013 to 2024.
Training
B.S.E., Duke University
M.D., Alpha Omega Alpha Honor Society, Southwestern Medical School in Dallas, Texas
Residency, Cornell University Medical Center and Sloan Kettering Cancer Center
Fellowships: Hematology-Oncology and Bone Marrow Transplant, Johns Hopkins School of Medicine
Foundation for the Accreditation of Cellular Therapy (FACT)
FACT Inspector- national organization that inspects and accredits bone marrow transplant programs nationally
FACT Accreditation Committee (2007-2008)
American Society of Blood and Marrow Transplant
ASBMT Board of Directors (2006-2009)
Society Memberships
American Society of Hematology
American Society of Clinical Oncology
American Society for Blood & Marrow Transplant
International Society for Experimental Hematology
American Association of Blood Banks
Past Awards:
Castle Connolly. American Top Doctors (2001-2006)
America’s Top Physicians, Consumers’ Research Council of America (2003-2009)
Past Academic Faculty Appointments
Johns Hopkins Faculty member, Bone Marrow Transplant Program
Assistant Director of the Johns Hopkins’ Hemapheresis Center.
Emory University-Associate Professor of Medicine, Bone Marrow Transplant Program
Director of Emory University’s Hemapheresis Center and Stem Cell Laboratory
Publications
Authored and co-authored over 250 research articles and abstracts in peer-reviewed journals: Blood, Journal of Clinical Oncology, Bone Marrow Transplantation, and Biology of Blood and Marrow Transplantation
Dr. Holland’s clinical and research interests include novel approaches to allogeneic blood and marrow transplantation and leukemia therapies.